Valuation: Becton, Dickinson and Company

Market Cap 42.2B 36.98B 34.33B 31.54B 59.44B 4,072B 60.31B 409B 160B 1,993B 158B 155B 6,883B P/E 2026 *
38.2x
P/E 2027 * 29.5x
Enterprise Value 58.72B 51.45B 47.76B 43.89B 82.7B 5,666B 83.92B 569B 223B 2,772B 220B 216B 9,577B EV / Sales 2026 *
3.06x
EV / Sales 2027 * 2.85x
Free-Float
74.04%
Yield 2026 *
2.51%
Yield 2027 * 2.56%
1 day-0.44%
1 week-1.11%
Current month+1.21%
1 month+8.85%
3 months-1.60%
6 months-25.66%
Current year-21.08%
1 week 151.97
Extreme 151.97
163.14
1 month 144.61
Extreme 144.61
163.14
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
287.32
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 2020-01-27
Director of Finance/CFO 44 2025-12-04
Compliance Officer - 2023-01-31
Director TitleAgeSince
Director/Board Member 75 2002-09-23
Director/Board Member 71 2010-07-25
Chairman 53 2021-04-27
Date Insider Type Main position Quantity % Market Cap.
7/2/26 Tax

Executive/Senior Manager

-1,935 0.0007%
6/26/26 Sell

Executive/Senior Manager

-75 0.0000%
6/24/26 Sell

Executive/Senior Manager

-1,100 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-0.44%-1.11%-15.51%-42.17% 42.2B
+0.90%+12.66%-20.01%-12.00% 175B
-0.56%+1.76%-10.65%-7.95% 105B
-0.82%+1.35%+2.60%+56.07% 58.48B
-0.82%-0.84%+33.62%+56.52% 51.36B
-4.89%-5.73% - - 31.44B
-4.44%-1.79%-16.08%-45.31% 27.56B
-0.23%-0.16%+63.73%-5.01% 25.32B
-0.56%-0.42%-5.87%-9.27% 20.52B
-1.86%-2.22%-12.83%-3.10% 19.89B
Average -1.17%+0.63%+2.11%-1.36% 55.68B
Weighted average by Cap. -0.23%+3.86%-4.95%-0.31%

Financials

2026 *2027 *
Net sales 19.21B 16.83B 15.63B 14.36B 27.06B 1,854B 27.46B 186B 72.87B 907B 72.12B 70.57B 3,134B 19.73B 17.28B 16.04B 14.74B 27.78B 1,903B 28.19B 191B 74.81B 931B 74.05B 72.45B 3,217B
Net income 1.12B 985M 915M 841M 1.58B 109B 1.61B 10.9B 4.27B 53.1B 4.22B 4.13B 183B 1.45B 1.27B 1.18B 1.08B 2.04B 140B 2.07B 14.04B 5.5B 68.43B 5.44B 5.32B 236B
Net Debt 16.51B 14.47B 13.43B 12.34B 23.26B 1,594B 23.6B 160B 62.63B 780B 61.99B 60.66B 2,694B 13.96B 12.23B 11.35B 10.43B 19.66B 1,347B 19.95B 135B 52.94B 659B 52.4B 51.27B 2,277B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
26-07-22 US$153.16 -0.44% 1,162,418
26-07-21 US$153.84 -0.41% 1,332,536
26-07-20 US$154.48 -2.33% 1,730,130
26-07-17 US$158.17 -1.10% 2,108,792
26-07-16 US$159.93 +3.26% 1,683,118
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
153.16USD
Average target price
179.36USD
Spread / Average Target
+17.11%

Quarterly revenue - Rate of surprise